Logo
Age related Macular Degeneration (AMD)

Improving Your Eye Care with Proactive Care

According to a published Ophthalmology study, 25% of age-related macular degeneration (AMD) cases go undetected - even with regular examinations using regular imaging tools. What’s more, additional studies show 78% of AMD patients do not seek treatment until their visual acuity is irreversibly damaged.

Earlier, More Accurate Detection
Structural changes (the appearance of drusen) in the retina are not always easily discernible. They often become evident only after AMD has progressed from a subclinical state. Impaired dark adaptation is 90.6% sensitive and 90.5% specific in identifying the earliest onset of AMD. Being able to identify the earliest AMD biomarker with such accuracy will greatly improve a patient's outcomes. We can detect AMD at the subclinical stage, at least three years before drusen are visible, when action can be taken to slow disease progression and prevent vision loss.


What is AMD?
How to Use the Amsler Grid


Monitoring Disease Progression

Functional testing and structural examinations may be useful for monitoring disease progression. More frequent visits increase our opportunity to detect choroidal neovascularization (CNV) before visual acuity loss. The follow-up interval may be shortened to every three or four months for patients who are progressing rapidly or are at high risk of CNV.


When detected early, many diseases can
be treated without further loss of vision.

MACULAR DEGENERATION (AMD) FAQs
OFFICE HOURS    
Mon
8:00 - 5:30
Tue
8:00 - 5:30
Wed
8:00 - 5:30
Thu
8:00 - 5:30
Fri
8:00 - 5:00
Sat
Closed
Sun
Closed
615 E Oklahoma, Ste 101
Enid, OK 73701
Map it!

CLINIC PHONE
(580) 233-4711

OPTICAL PHONE
(580) 242-0511
Facebook
Enid Eye, Inc. 615 E Oklahoma Ste 101 Enid, OK 73701 Phone: (580) 233-4711

© 2021 All content is the property of Enid Eye, Inc. ™ & assoc. vendors. | DISCLAIMER | HIPAA
Website Powered and Developed by EyeVertise.com

Internal email | Internal forms